Ephrin or not? Six tough questions on Eph targeting
- 3 May 2020
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 24 (5) , 403-415
Abstract
Introduction: The Eph-ephrin is a cell-cell communication system generating a forward signal in cell expressing Eph receptors and a reverse signal in ephrin-ligand expressing cells. While clearly involved in the insurgence and progression of cancer, the understanding of the molecular mechanisms regulated by this system needs development; this is a hurdle to the development of therapeutic strategies that can target the Eph receptors and/or their ephrin ligands. Areas covered: We have taken the opportunity to share some key questions on the most effective strategies to target the Eph-ephrin system. This article is based on our experience of the field and therefore is a Perspective and not comprehensive examination of the literature. Expert opinion: Targeting of the Eph-ephrin system has emerged as a potentially valuable approach for cancer therapy. Pharmacological tools have been reported in the last 15 years and these include forward signaling blockers such as kinases inhibitors and antagonists of forward and reverse signaling. Also, biologics including antibodies and recombinant proteins have been developed and some have reached early clinical stages. Data deem the Eph-ephrin system as a signaling axis that is an elusive target. A better understanding of the basic pharmacology behind the activity of available agents and a comprehensive knowledge of the ephrin biology are necessary. We are looking forward to knowing the opinion of the readers.Keywords
This publication has 72 references indexed in Scilit:
- Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumorsInvestigational New Drugs, 2012
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer CellsJournal of Medicinal Chemistry, 2012
- Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cellsCellular Signalling, 2011
- EphB Signaling Controls Lineage Plasticity of Adult Neural Stem Cell Niche CellsCell Stem Cell, 2010
- Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 ReceptorBiochemistry, 2010
- Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews Cancer, 2010
- Discovery and structural analysis of Eph receptor tyrosine kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with AktCancer Cell, 2009
- Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptorOncogene, 2008
- Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signalingNature Neuroscience, 2004